385 related articles for article (PubMed ID: 34787462)
1. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis.
Lu H; Gao NL; Tong F; Wang J; Li H; Zhang R; Ma H; Yang N; Zhang Y; Wang Y; Liang Z; Zeng H; Chen WH; Dong X
Microbiol Spectr; 2021 Dec; 9(3):e0080221. PubMed ID: 34787462
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and its metabolites in non-small cell lung cancer and brain metastasis: from alteration to potential microbial markers and drug targets.
Jiang H; Zeng W; Zhang X; Li Y; Wang Y; Peng A; Cao D
Front Cell Infect Microbiol; 2023; 13():1211855. PubMed ID: 38304459
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
[TBL] [Abstract][Full Text] [Related]
4. The Core Gut Microbiome of the American Cockroach, Periplaneta americana, Is Stable and Resilient to Dietary Shifts.
Tinker KA; Ottesen EA
Appl Environ Microbiol; 2016 Nov; 82(22):6603-6610. PubMed ID: 27590811
[TBL] [Abstract][Full Text] [Related]
5. The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease.
Zhang L; Lu QY; Wu H; Cheng YL; Kang J; Xu ZG
Microbiol Spectr; 2023 Aug; 11(4):e0038223. PubMed ID: 37341590
[TBL] [Abstract][Full Text] [Related]
6. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.
Zhang C; Wang J; Sun Z; Cao Y; Mu Z; Ji X
Cancer Sci; 2021 Aug; 112(8):3005-3017. PubMed ID: 34028936
[TBL] [Abstract][Full Text] [Related]
7. Broad-spectrum antibiotics associated gut microbiome disturbance impairs T cell immunity and promotes lung cancer metastasis: a retrospective study.
Xu K; Cai J; Xing J; Li X; Wu B; Zhu Z; Zhang Z
BMC Cancer; 2022 Nov; 22(1):1182. PubMed ID: 36384523
[TBL] [Abstract][Full Text] [Related]
8. Characterization of gut microbiota in patients with stage 3-4 chronic kidney disease: a retrospective cohort study.
Yang X; Cai S; Gong J; Zhang J; Lian M; Chen R; Zhou L; Bai P; Liu B; Zhuang M; Tan H; Xu J; Li M
Int Urol Nephrol; 2024 May; 56(5):1751-1762. PubMed ID: 38085410
[TBL] [Abstract][Full Text] [Related]
9. The association between gut butyrate-producing bacteria and non-small-cell lung cancer.
Gui Q; Li H; Wang A; Zhao X; Tan Z; Chen L; Xu K; Xiao C
J Clin Lab Anal; 2020 Aug; 34(8):e23318. PubMed ID: 32227387
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the gut microbiota in patients with chronic kidney disease.
Hu X; Ouyang S; Xie Y; Gong Z; Du J
Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
[No Abstract] [Full Text] [Related]
11. Microbiota bacteriana intestinal en pacientes mexicanos con inmunodeficiencia común variable.
Franco-Esquivias AP; García-De la Peña C; Torres-Lozano C; Vaca-Paniagua F; Díaz-Velásquez C; Ortega-Cisneros M; Quintero-Ramos A
Gac Med Mex; 2019; 155(5):481-486. PubMed ID: 31695233
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in Mexican patients with common variable immunodeficiency.
Franco-Esquivias AP; Peña CG; Torres-Lozano C; Vaca-Paniagua F; Díaz-Velásquez C; Ortega-Cisneros M; Quintero-Ramos A
Gac Med Mex; 2019; 155(5):447-452. PubMed ID: 32091022
[TBL] [Abstract][Full Text] [Related]
13. Impact of Gut Dysbiosis on the Risk of Non-Small-Cell Lung Cancer.
Wei YF; Huang MS; Huang CH; Yeh YT; Hung CH
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498063
[TBL] [Abstract][Full Text] [Related]
14. Specific gut microbiome signature predicts the early-stage lung cancer.
Zheng Y; Fang Z; Xue Y; Zhang J; Zhu J; Gao R; Yao S; Ye Y; Wang S; Lin C; Chen S; Huang H; Hu L; Jiang GN; Qin H; Zhang P; Chen J; Ji H
Gut Microbes; 2020 Jul; 11(4):1030-1042. PubMed ID: 32240032
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the Gut Microbiome in Hypertension.
Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
[No Abstract] [Full Text] [Related]
16. Lung microbiome alterations in NSCLC patients.
Zheng L; Sun R; Zhu Y; Li Z; She X; Jian X; Yu F; Deng X; Sai B; Wang L; Zhou W; Wu M; Li G; Tang J; Jia W; Xiang J
Sci Rep; 2021 Jun; 11(1):11736. PubMed ID: 34083661
[TBL] [Abstract][Full Text] [Related]
17. Alveolar microbiota profile in patients with human pulmonary tuberculosis and interstitial pneumonia.
Vázquez-Pérez JA; Carrillo CO; Iñiguez-García MA; Romero-Espinoza I; Márquez-García JE; Falcón LI; Torres M; Herrera MT
Microb Pathog; 2020 Feb; 139():103851. PubMed ID: 31715320
[TBL] [Abstract][Full Text] [Related]
18. Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer.
Liu F; Li J; Guan Y; Lou Y; Chen H; Xu M; Deng D; Chen J; Ni B; Zhao L; Li H; Sang H; Cai X
Int J Biol Sci; 2019; 15(11):2381-2392. PubMed ID: 31595156
[TBL] [Abstract][Full Text] [Related]
19. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
Li F; Wang M; Wang J; Li R; Zhang Y
Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
[TBL] [Abstract][Full Text] [Related]
20. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.
Elison E; Vigsnaes LK; Rindom Krogsgaard L; Rasmussen J; Sørensen N; McConnell B; Hennet T; Sommer MO; Bytzer P
Br J Nutr; 2016 Oct; 116(8):1356-1368. PubMed ID: 27719686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
